| pubmed-article:20080255 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20080255 | lifeskim:mentions | umls-concept:C0040732 | lld:lifeskim |
| pubmed-article:20080255 | lifeskim:mentions | umls-concept:C0005955 | lld:lifeskim |
| pubmed-article:20080255 | lifeskim:mentions | umls-concept:C1801960 | lld:lifeskim |
| pubmed-article:20080255 | lifeskim:mentions | umls-concept:C0302189 | lld:lifeskim |
| pubmed-article:20080255 | lifeskim:mentions | umls-concept:C1515895 | lld:lifeskim |
| pubmed-article:20080255 | lifeskim:mentions | umls-concept:C2348628 | lld:lifeskim |
| pubmed-article:20080255 | lifeskim:mentions | umls-concept:C1514485 | lld:lifeskim |
| pubmed-article:20080255 | lifeskim:mentions | umls-concept:C1292733 | lld:lifeskim |
| pubmed-article:20080255 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:20080255 | pubmed:dateCreated | 2011-5-2 | lld:pubmed |
| pubmed-article:20080255 | pubmed:abstractText | Transplant arteriosclerosis is characterized by intraluminal obstructive proliferation occurring in response to immune-mediated arterial wall injury. Cell therapy with vascular progenitor cells have been suggested to repair intimal lesions following endothelial injury. The aim of the current study was to assess the effects of autologous bone marrow cell direct transfer and of Fucan-mobilization bone marrow-derived progenitor cells on intimal thickening in vascular grafts. | lld:pubmed |
| pubmed-article:20080255 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20080255 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20080255 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20080255 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20080255 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20080255 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20080255 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:20080255 | pubmed:issn | 1095-8673 | lld:pubmed |
| pubmed-article:20080255 | pubmed:author | pubmed-author:ThuillezChris... | lld:pubmed |
| pubmed-article:20080255 | pubmed:author | pubmed-author:BoyerOlivierO | lld:pubmed |
| pubmed-article:20080255 | pubmed:author | pubmed-author:PlissonnierDi... | lld:pubmed |
| pubmed-article:20080255 | pubmed:author | pubmed-author:LallemandFran... | lld:pubmed |
| pubmed-article:20080255 | pubmed:author | pubmed-author:BessouJean... | lld:pubmed |
| pubmed-article:20080255 | pubmed:author | pubmed-author:AlkhatibBassa... | lld:pubmed |
| pubmed-article:20080255 | pubmed:author | pubmed-author:Freguin-Bouil... | lld:pubmed |
| pubmed-article:20080255 | pubmed:author | pubmed-author:DavidNathalie... | lld:pubmed |
| pubmed-article:20080255 | pubmed:copyrightInfo | Copyright © 2011 Elsevier Inc. All rights reserved. | lld:pubmed |
| pubmed-article:20080255 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20080255 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:20080255 | pubmed:volume | 168 | lld:pubmed |
| pubmed-article:20080255 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20080255 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20080255 | pubmed:pagination | 143-8 | lld:pubmed |
| pubmed-article:20080255 | pubmed:meshHeading | pubmed-meshheading:20080255... | lld:pubmed |
| pubmed-article:20080255 | pubmed:meshHeading | pubmed-meshheading:20080255... | lld:pubmed |
| pubmed-article:20080255 | pubmed:meshHeading | pubmed-meshheading:20080255... | lld:pubmed |
| pubmed-article:20080255 | pubmed:meshHeading | pubmed-meshheading:20080255... | lld:pubmed |
| pubmed-article:20080255 | pubmed:meshHeading | pubmed-meshheading:20080255... | lld:pubmed |
| pubmed-article:20080255 | pubmed:meshHeading | pubmed-meshheading:20080255... | lld:pubmed |
| pubmed-article:20080255 | pubmed:meshHeading | pubmed-meshheading:20080255... | lld:pubmed |
| pubmed-article:20080255 | pubmed:meshHeading | pubmed-meshheading:20080255... | lld:pubmed |
| pubmed-article:20080255 | pubmed:meshHeading | pubmed-meshheading:20080255... | lld:pubmed |
| pubmed-article:20080255 | pubmed:meshHeading | pubmed-meshheading:20080255... | lld:pubmed |
| pubmed-article:20080255 | pubmed:meshHeading | pubmed-meshheading:20080255... | lld:pubmed |
| pubmed-article:20080255 | pubmed:meshHeading | pubmed-meshheading:20080255... | lld:pubmed |
| pubmed-article:20080255 | pubmed:meshHeading | pubmed-meshheading:20080255... | lld:pubmed |
| pubmed-article:20080255 | pubmed:meshHeading | pubmed-meshheading:20080255... | lld:pubmed |
| pubmed-article:20080255 | pubmed:meshHeading | pubmed-meshheading:20080255... | lld:pubmed |
| pubmed-article:20080255 | pubmed:meshHeading | pubmed-meshheading:20080255... | lld:pubmed |
| pubmed-article:20080255 | pubmed:meshHeading | pubmed-meshheading:20080255... | lld:pubmed |
| pubmed-article:20080255 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:20080255 | pubmed:articleTitle | Syngeneic bone marrow cell therapy prevents intimal proliferation in allogeneic vascular transplantation. | lld:pubmed |
| pubmed-article:20080255 | pubmed:affiliation | Nephrology Department, Rouen University Hospital, Rouen, France. | lld:pubmed |
| pubmed-article:20080255 | pubmed:publicationType | Journal Article | lld:pubmed |
